EXACT Sciences Corp. (EXAS)
NCM · Common · CUSIP 30063P105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for EXAS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
30063P105
Market Cap
Large Cap
IPO
1/31/2001 · $14.00/share
Business: Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting their noninvasive, molecular screening technology for the detection of colorectal cancer. The company manufactures, and offers through their clinical lab subsidiary, Cologuard, which is the first and only FDA approved stool DNA non-invasive colorectal cancer screening test. Cologuard is included in the colorectal cancer screening guidelines of the American Cancer Society and stool DNA is included in the U.S. Multi-Society Task Force on Colorectal Cancer.

Company Contact

CEO
Kevin T. Conroy
CFO
Aaron Bloomer
Headquarters
5505 Endeavor Lane, Madison, WI 53719
Phone
608-284-5700
Fax
608-284-5701
Investor Relations
608-284-5700
Email Form
Contact Form »
SEC EDGAR Filings
View filings »